Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 583-584, November 2009

Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer

Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(09)00193-8

doi:10.1016/j.urolonc.2009.06.011

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 583-584, November 2009

Article Tools